Literature DB >> 12521146

Homocysteine, folate deficiency, and Parkinson's disease.

Joshua W Miller1.   

Abstract

Folate deficiency sensitizes mice to dopaminergic neurodegeneration and motor dysfunction caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Additional experiments indicate that this effect of folate deficiency may be mediated by homocysteine. These findings suggest that folate deficiency and hyperhomocysteinemia are risk factors for Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12521146     DOI: 10.1301/002966402320964089

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  6 in total

1.  Glycine N-methyltransferase expression in the hippocampus and its role in neurogenesis and cognitive performance.

Authors:  Manuel Carrasco; Luis G Rabaneda; Maribel Murillo-Carretero; Sylvia Ortega-Martínez; María L Martínez-Chantar; Ashwin Woodhoo; Zigmund Luka; Conrad Wagner; Shelly C Lu; José M Mato; Juan A Micó; Carmen Castro
Journal:  Hippocampus       Date:  2014-04-08       Impact factor: 3.899

2.  Serum iron, vitamin B12 and folic acid levels in Parkinson's disease.

Authors:  Gulizar Madenci; Sule Bilen; Berna Arli; Mustafa Saka; Fikri Ak
Journal:  Neurochem Res       Date:  2012-02-26       Impact factor: 3.996

3.  Effect of entacapone on plasma homocysteine levels in Parkinson's disease patients.

Authors:  Martin Nevrly; Petr Kanovsky; Hana Vranova; Katerina Langova; Petr Hlustik
Journal:  Neurol Sci       Date:  2010-05-13       Impact factor: 3.307

4.  The sigma receptor ligand (+)-pentazocine prevents apoptotic retinal ganglion cell death induced in vitro by homocysteine and glutamate.

Authors:  Pamela Moore Martin; Mohammad S Ola; Neeraj Agarwal; Vadivel Ganapathy; Sylvia B Smith
Journal:  Brain Res Mol Brain Res       Date:  2004-04-07

Review 5.  The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease.

Authors:  Elizabeth A Mazzio; Fran Close; Karam F A Soliman
Journal:  Int J Mol Sci       Date:  2011-01-17       Impact factor: 5.923

6.  Potential Role of Caffeine in the Treatment of Parkinson's Disease.

Authors:  Mohsin H K Roshan; Amos Tambo; Nikolai P Pace
Journal:  Open Neurol J       Date:  2016-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.